Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pyoderma Gangrenosum”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Study completedNCT01965613
What this trial is testing

A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Janssen Research & Development, LLC 10
Testing effectiveness (Phase 2)WithdrawnNCT00730717
What this trial is testing

Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Wright State University
Large-scale testing (Phase 3)Ended earlyNCT05343754
What this trial is testing

Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Erasmus Medical Center 3
Large-scale testing (Phase 3)Ended earlyNCT05964413
What this trial is testing

Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
InflaRx GmbH 54
Testing effectiveness (Phase 2)Looking for participantsNCT07337564
What this trial is testing

A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Shandong First Medical University 10
Not applicableUnknownNCT04792957
What this trial is testing

JAK-STAT Signaling Pathway in Pyoderma Gangrenosum

Who this might be right for
Pyoderma GangrenosumHidradenitis SuppurativaPsoriasis
Dokuz Eylul University 120
Not applicableStudy completedNCT00791557
What this trial is testing

Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

Who this might be right for
Pyoderma GangrenosumCrohn's DiseaseUlcerative Colitis+1 more
University Hospitals Cleveland Medical Center 2
Not applicableStudy completedNCT04750213
What this trial is testing

Assess Adverse Events and Change in Disease State in Adult Participants Being Treated With Humira in Participants Diagnosed With Pyoderma Gangrenosum (PG)

Who this might be right for
Pyoderma Gangrenosum
AbbVie 60
Testing effectiveness (Phase 2)Study completedNCT03137160
What this trial is testing

An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Ohio State University 4
Testing effectiveness (Phase 2)Study completedNCT02733094
What this trial is testing

Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Technical University of Munich 8
Not applicableUnknownNCT03636737
What this trial is testing

Study on the Clinical Features, Comorbidities and Pathologies Associated With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Assistance Publique Hopitaux De Marseille 140
Large-scale testing (Phase 3)Ended earlyNCT02318914
What this trial is testing

A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
XOMA (US) LLC 15
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Emerging Indications for Hyperbaric Oxygen Treatment

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Testing effectiveness (Phase 2)WithdrawnNCT04274166
What this trial is testing

Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Ended earlyNCT03072953
What this trial is testing

Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Arena Pharmaceuticals 2
Testing effectiveness (Phase 2)Study completedNCT01302795
What this trial is testing

Canakinumab for Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
University of Zurich 5
Large-scale testing (Phase 3)Looking for participantsNCT06624670
What this trial is testing

Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
LEO Pharma 90
Testing effectiveness (Phase 2)Study completedNCT04901325
What this trial is testing

Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)

Who this might be right for
Pyoderma GangrenosumSkin DiseasesWound Heal+2 more
Oregon Health and Science University 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07444684
What this trial is testing

Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Testing effectiveness (Phase 2)Ended earlyNCT06092216
What this trial is testing

Spesolimab in Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Icahn School of Medicine at Mount Sinai 5
Next Page